Clinical Trials Browser

Interventional × dolastatin 10 × Gastrointestinal × Clear all

NCT00003677 2018-10-25

Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00003557 2014-03-06

Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer

Phase 2 Completed

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms